Roche has announced a pair of licensing deals with Poseida Therapeutics and Kiniksa Pharmaceuticals that bolster its pipeline in cancer and inflammatory diseases. The agreement with Poseida is by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback